Arch Pathol Lab Med. 2018 Feb;142(2):268-274. doi: 10.5858/arpa.2016-0380-RSR2.
Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and its higher-grade counterpart, dedifferentiated liposarcoma (DDL), are extraordinarily rare tumors in the breast. The main differential diagnostic consideration of primary breast ALT/WDL is malignant phyllodes tumor with liposarcomatous differentiation, and the main differential diagnostic consideration of DDL in the breast is metaplastic breast carcinoma, particularly the spindle cell type, with heterologous sarcomatous differentiation. These differential diagnoses may be particularly challenging when evaluating limited core needle biopsy sampling. MDM2 and/or CDK4 protein overexpression and gene amplification are beneficial ancillary studies that can help establish the diagnosis of primary breast ALT/WDL and DDL, and effectively rule out the diagnoses of malignant phyllodes tumor and metaplastic breast carcinoma.
非典型性脂肪肉瘤/高分化脂肪肉瘤(ALT/WDL)及其高级别对应物去分化脂肪肉瘤(DDL)在乳腺中极为罕见。原发性乳腺 ALT/WDL 的主要鉴别诊断考虑是具有脂肪肉瘤分化的恶性叶状肿瘤,而乳腺 DDL 的主要鉴别诊断考虑是化生性乳腺癌,特别是具有异源性肉瘤分化的梭形细胞型。在评估有限的核心针活检样本时,这些鉴别诊断可能特别具有挑战性。MDM2 和/或 CDK4 蛋白过表达和基因扩增是有益的辅助研究,可以帮助确立原发性乳腺 ALT/WDL 和 DDL 的诊断,并有效地排除恶性叶状肿瘤和化生性乳腺癌的诊断。